Literature DB >> 20393874

Generating ceramide from sphingomyelin by alkaline sphingomyelinase in the gut enhances sphingomyelin-induced inhibition of cholesterol uptake in Caco-2 cells.

Dan Feng1, Lena Ohlsson, Wenhua Ling, Ake Nilsson, Rui-Dong Duan.   

Abstract

Background Sphingomyelin (SM) is present in dietary products and cell plasma membranes. We previously showed that dietary SM inhibited cholesterol absorption in rats. In the intestinal tract, SM is mainly hydrolyzed by alkaline sphingomyelinase (alk-SMase) to ceramide.Aims We investigated the influence of SM and its hydrolytic products ceramide and sphingosine on cholesterol uptake in intestinal Caco-2 cells.Methods Micelles containing bile salt, monoolein, and (14)C-cholesterol were prepared with or without SM, ceramide,or sphingosine. The micelles were incubated with Caco-2 cells, and uptake of radioactive cholesterol was quantified.Results We found that confluent monolayer Caco-2 cells expressed NPC1L1, and the uptake of cholesterol in the cells was inhibited by ezetimibe, a specific inhibitor of NPC1L1. Incorporation of SM in the cholesterol micelles inhibited cholesterol uptake dose-dependently; 38% inhibition occurred at an equal mole ratio of SM and cholesterol.The inhibition was further enhanced to 45% by pretreating the cholesterol/SM micelles with recombinant alk-SMase, which hydrolyzed SM in the micelles by 85%, indicating ceramide has stronger inhibitory effects on cholesterol uptake. To confirm this, we further replaced SM in the micelles with ceramide and sphingosine, and found that at equal mole ratio to cholesterol, ceramide exhibited stronger inhibitory effect (50% vs 38%) on cholesterol uptake than SM, whereas sphingosine only had a weak effect at high concentrations.Conclusion Both SM and ceramide inhibit cholesterol uptake, the effect of ceramide being stronger than that of SM. Alk-SMase enhances SM-induced inhibition of cholesterol uptake by generating ceramide in the intestinal lumen.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20393874     DOI: 10.1007/s10620-010-1202-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

Review 1.  Intestinal cholesterol absorption.

Authors:  P A Dawson; L L Rudel
Journal:  Curr Opin Lipidol       Date:  1999-08       Impact factor: 4.776

2.  The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract.

Authors:  A Nilsson
Journal:  Biochim Biophys Acta       Date:  1969-03-04

3.  Ceramide drives cholesterol out of the ordered lipid bilayer phase into the crystal phase in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine/cholesterol/ceramide ternary mixtures.

Authors:  Md Rejwan Ali; Kwan Hon Cheng; Juyang Huang
Journal:  Biochemistry       Date:  2006-10-17       Impact factor: 3.162

4.  N-palmitoyl sphingomyelin bilayers: structure and interactions with cholesterol and dipalmitoylphosphatidylcholine.

Authors:  P R Maulik; G G Shipley
Journal:  Biochemistry       Date:  1996-06-18       Impact factor: 3.162

5.  Purification, characterization, and expression of rat intestinal alkaline sphingomyelinase.

Authors:  Yajun Cheng; Ake Nilsson; Elisabeth Tömquist; Rui-Dong Duan
Journal:  J Lipid Res       Date:  2002-02       Impact factor: 5.922

6.  Distribution and properties of neutral ceramidase activity in rat intestinal tract.

Authors:  P Lundgren; A Nilsson; R D Duan
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

7.  Cholesterol and sphingomyelin syntheses are regulated independently in cultured human intestinal cells, CaCo-2: role of membrane cholesterol and sphingomyelin content.

Authors:  H Chen; E Born; S N Mathur; F J Field
Journal:  J Lipid Res       Date:  1993-12       Impact factor: 5.922

8.  Pancreatic trypsin cleaves intestinal alkaline sphingomyelinase from mucosa and enhances the sphingomyelinase activity.

Authors:  Jun Wu; Fuli Liu; Ake Nilsson; Rui-Dong Duan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-06-17       Impact factor: 4.052

9.  Milk sphingomyelin is more effective than egg sphingomyelin in inhibiting intestinal absorption of cholesterol and fat in rats.

Authors:  Sang K Noh; Sung I Koo
Journal:  J Nutr       Date:  2004-10       Impact factor: 4.798

Review 10.  Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.

Authors:  Harry R Davis; Enrico P Veltri
Journal:  J Atheroscler Thromb       Date:  2007-06       Impact factor: 4.928

View more
  12 in total

Review 1.  Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke.

Authors:  Tzipora Goldkorn; Simone Filosto
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-04       Impact factor: 6.914

2.  Crucial role of alkaline sphingomyelinase in sphingomyelin digestion: a study on enzyme knockout mice.

Authors:  Yao Zhang; Yajun Cheng; Gert H Hansen; Lise-Lotte Niels-Christiansen; Frank Koentgen; Lena Ohlsson; Ake Nilsson; Rui-Dong Duan
Journal:  J Lipid Res       Date:  2010-12-21       Impact factor: 5.922

3.  Dairy products and plasma cholesterol levels.

Authors:  Lena Ohlsson
Journal:  Food Nutr Res       Date:  2010-08-19       Impact factor: 3.894

4.  Hepatic accumulation of intestinal cholesterol is decreased and fecal cholesterol excretion is increased in mice fed a high-fat diet supplemented with milk phospholipids.

Authors:  Alvin Kamili; Elaine Wat; Rosanna Ws Chung; Sally Tandy; Jacquelyn M Weir; Peter J Meikle; Jeffrey S Cohn
Journal:  Nutr Metab (Lond)       Date:  2010-12-31       Impact factor: 4.169

Review 5.  The Role of Sphingolipids on Innate Immunity to Intestinal Salmonella Infection.

Authors:  Fu-Chen Huang
Journal:  Int J Mol Sci       Date:  2017-08-07       Impact factor: 5.923

Review 6.  Dietary Cholesterol, Serum Lipids, and Heart Disease: Are Eggs Working for or Against You?

Authors:  Christopher N Blesso; Maria Luz Fernandez
Journal:  Nutrients       Date:  2018-03-29       Impact factor: 5.717

Review 7.  The Impact of Egg Nutrient Composition and Its Consumption on Cholesterol Homeostasis.

Authors:  Heqian Kuang; Fang Yang; Yan Zhang; Tiannan Wang; Guoxun Chen
Journal:  Cholesterol       Date:  2018-08-23

8.  Milk polar lipids favorably alter circulating and intestinal ceramide and sphingomyelin species in postmenopausal women.

Authors:  Mélanie Le Barz; Cécile Vors; Emmanuel Combe; Laurie Joumard-Cubizolles; Manon Lecomte; Florent Joffre; Michèle Trauchessec; Sandra Pesenti; Emmanuelle Loizon; Anne-Esther Breyton; Emmanuelle Meugnier; Karène Bertrand; Jocelyne Drai; Chloé Robert; Annie Durand; Charlotte Cuerq; Patrice Gaborit; Nadine Leconte; Annick Bernalier-Donadille; Eddy Cotte; Martine Laville; Stéphanie Lambert-Porcheron; Lemlih Ouchchane; Hubert Vidal; Corinne Malpuech-Brugère; David Cheillan; Marie-Caroline Michalski
Journal:  JCI Insight       Date:  2021-05-24

9.  Dietary sphingomyelin lowers hepatic lipid levels and inhibits intestinal cholesterol absorption in high-fat-fed mice.

Authors:  Rosanna W S Chung; Alvin Kamili; Sally Tandy; Jacquelyn M Weir; Raj Gaire; Gerard Wong; Peter J Meikle; Jeffrey S Cohn; Kerry-Anne Rye
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

Review 10.  Metabolism, physiological role, and clinical implications of sphingolipids in gastrointestinal tract.

Authors:  Krzysztof Kurek; Bartłomiej Łukaszuk; Dominika M Piotrowska; Patrycja Wiesiołek; Anna Małgorzata Chabowska; Małgorzata Zendzian-Piotrowska
Journal:  Biomed Res Int       Date:  2013-09-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.